Research programme: anti-amyloid beta antibody gene therapy - Voyager Therapeutics
Latest Information Update: 08 Jan 2024
At a glance
- Originator Voyager Therapeutics
- Class Antidementias; Gene therapies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Alzheimer's disease